• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Oramed Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010 Product Image

Oramed Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

  • ID: 1446175
  • November 2010
  • 42 pages
  • GlobalData

Oramed Pharmaceuticals, Inc. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Oramed Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Oramed Pharmaceuticals, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Oramed Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including READ MORE >



List of Tables
List of Figures
Oramed Pharmaceuticals, Inc. Snapshot
Oramed Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Oramed Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Oramed Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Oramed Pharmaceuticals, Inc. – Pipeline Products Glance
Oramed Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Oramed Pharmaceuticals, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Oramed Pharmaceuticals, Inc. – Drug Profiles
ORMD-0801
Product Description
Mechanism of Action
R&D Progress
ORMD-0802
Product Description
Mechanism of Action
R&D Progress
ORMD-0901
Product Description
Mechanism of Action
R&D Progress
ORMD-1001
Product Description
Mechanism of Action
R&D Progress
Oramed Pharmaceuticals, Inc. – Pipeline Analysis
Oramed Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
Oramed Pharmaceuticals, Inc. Pipeline Products By Target
Oramed Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
Oramed Pharmaceuticals, Inc. – Pipeline Products by Molecule Type
Oramed Pharmaceuticals, Inc. – Recent Pipeline Updates
Oramed Pharmaceuticals, Inc. – Company Statement
Oramed Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Recent Developments
Nov 15, 2010: Oramed Presents Phase IIb Clinical Trial Results Of ORMD-0801 At Diabetes Technology Meeting 2010
Sep 14, 2010: Oramed Announces Successful Results From Exploratory Clinical Study Of ORMD-0801 In Type I Diabetes
Jun 28, 2010: Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association
May 26, 2010: Oramed Announces Publication Of Research Article On ORMD-0801 In Diabetes, Obesity And Metabolism
May 06, 2010: Oramed Reports Phase IIb Trial Results Of ORMD- 0801 In Type 2 Diabetes Patients
Mar 25, 2010: Oramed Completes Pivotal Phase IIb Clinical Trial Of ORMD-0801 For Type 2 Diabetes
Jan 19, 2010: Oramed Pharmaceuticals Announces Completion Of Patient Enrollment For Pivotal Phase 2B Clinical Trials Of ORMD-0801
Oct 20, 2009: Oramed Pharmaceuticals To Present Results Of A GLP-1 b Analog Oral Administration Study At The Diabetes Technology Society’s Ninth Annual Meeting
Sep 09, 2009: Oramed Pharmaceticals Commences Human Clinical Trials Of An Oral GLP-1 Analog ORMD 0901
Jul 21, 2009: Oramed Pharmaceuticals Reports Positive Results From A Study Of Oral Insulin Capsule On Type 1 Diabetic Patients
Financial Deals Landscape
Oramed Pharmaceuticals, Inc., Deals Volume Summary, 2004 to YTD 2010
Oramed Pharmaceuticals, Inc., Deals Summary By Region, 2004 to YTD 2010
Oramed Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2010
Oramed Pharmaceuticals, Inc. Detailed Deal Summary
Asset Purchase
Oramed Acquires Patent And Related Intellectual Property From Hadasit Medical
Equity Offering
Oramed Pharmaceuticals Completes Private Placement Of $5 Million
Oramed Pharmaceuticals Completes Private Placement Of $2 Million
Oramed Pharmaceuticals Completes Private Placement Of $0.02 Million
Oramed Pharmaceuticals Files Shelf Registration Statement For Public Offering Of 24 Million Shares
Debt Offering
Oramed Pharmaceuticals Completes Private Placement Of $0.12 Million
Oramed Pharmaceuticals Enters Into Co-Development Agreement With Encorium Group
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS